Affymetrix Inc. employee Linda Ange inspects a finished gene chip at the company’s production facilities. Gene chips are dime-sized pieces of glass, infused with DNA fragments,that allow researchers to study how and why genes react to various stimuli. Industry leader Affymetrix, with estimates of up to 80 percent of the commercial market, shipped 280,000 gene chips last year.
Steven Potter is attempting to grow kidneys in his laboratory in hopes of someday saving the lives of patients who now die awaiting organ transplants.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
